Improving quality of life for people with ascites: REDUCe 2 Study
Ascites is a build-up of fluid in your tummy (abdomen). It is the most common complication of liver cirrhosis. Ascites can cause severe symptoms such as pain and breathlessness. Initially ascites can be treated with water tablets. But if the liver condition gets...
Help us identify barriers to accessing liver services in Scotland
We have partnered with the Scottish Hepatology Access Research Partnership (SHARP) to identify the barriers that are faced by people accessing liver services in Scotland, and how these barriers can be removed. In order to achieve this, we need your help. If you have a...
New Clinical Trial for primary sclerosing cholangitis
Asp-PSC is a ground-breaking clinical trial that aims to see if the risk of cancer for people with primary sclerosing cholangitis (PSC) can be reduced. PSC is a rare autoimmune liver disease affecting around 3,000 to 4,000 people in the UK. It is closely associated...
New study shows macrophage cell therapy holds promise to treat people with liver cirrhosis
A study led by the University of Edinburgh has looked at a new type of cell therapy for people with cirrhosis. They found that the treatment could reduce the risk of serious liver complications, and could in future help to prevent hospital admissions and deaths. At...